YMTX logo

Yumanity Therapeutics (YMTX) Cash From Investing

Annual CFI

$3.09 M
-$27.95 M-90.04%

December 31, 2021


Summary


Performance

YMTX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherYMTXcash flowmetrics:

Quarterly CFI

$0.00
-$1.66 M-100.00%

September 30, 2022


Summary


Performance

YMTX Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherYMTXcash flowmetrics:

TTM CFI

$3.21 M
-$5.38 M-62.63%

September 30, 2022


Summary


Performance

YMTX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherYMTXcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

YMTX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-90.0%-100.0%-90.8%
3 y3 years-90.7%-100.0%+171.9%
5 y5 years-90.7%-100.0%+171.9%

YMTX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low-100.0%<-9999.0%-65.6%-3.6%
5 y5-year-90.7%at low-100.0%<-9999.0%-90.8%-175.0%
alltimeall time-90.7%at low-100.0%<-9999.0%-90.8%-175.0%

Yumanity Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2022
-
$0.00(-100.0%)
$3.21 M(-62.6%)
Jun 2022
-
$1.66 M(-3237.7%)
$8.59 M(-7.8%)
Mar 2022
-
-$53.00 K(-103.3%)
$9.31 M(+201.2%)
Dec 2021
$3.09 M
$1.60 M(-70.3%)
$3.09 M(-91.1%)
Sep 2021
-
$5.38 M(+124.9%)
$34.94 M(+34.6%)
Jun 2021
-
$2.39 M(-138.1%)
$25.96 M(+10.1%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$6.28 M(-118.8%)
$23.59 M(-24.0%)
Dec 2020
$31.04 M(-6.6%)
$33.45 M(-1029.1%)
$31.04 M(-1389.6%)
Sep 2020
-
-$3.60 M(<-9900.0%)
-$2.41 M(-301.8%)
Jun 2020
-
$13.00 K(-98.9%)
$1.19 M(+1.1%)
Mar 2020
-
$1.18 M
$1.18 M
Dec 2019
$33.25 M
-
-

FAQ

  • What is Yumanity Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Yumanity Therapeutics?
  • What is Yumanity Therapeutics annual CFI year-on-year change?
  • What is Yumanity Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Yumanity Therapeutics?
  • What is Yumanity Therapeutics quarterly CFI year-on-year change?
  • What is Yumanity Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Yumanity Therapeutics?
  • What is Yumanity Therapeutics TTM CFI year-on-year change?

What is Yumanity Therapeutics annual cash flow from investing activities?

The current annual CFI of YMTX is $3.09 M

What is the all time high annual CFI for Yumanity Therapeutics?

Yumanity Therapeutics all-time high annual cash flow from investing activities is $33.25 M

What is Yumanity Therapeutics annual CFI year-on-year change?

Over the past year, YMTX annual cash flow from investing activities has changed by -$27.95 M (-90.04%)

What is Yumanity Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of YMTX is $0.00

What is the all time high quarterly CFI for Yumanity Therapeutics?

Yumanity Therapeutics all-time high quarterly cash flow from investing activities is $33.45 M

What is Yumanity Therapeutics quarterly CFI year-on-year change?

Over the past year, YMTX quarterly cash flow from investing activities has changed by -$5.38 M (-100.00%)

What is Yumanity Therapeutics TTM cash flow from investing activities?

The current TTM CFI of YMTX is $3.21 M

What is the all time high TTM CFI for Yumanity Therapeutics?

Yumanity Therapeutics all-time high TTM cash flow from investing activities is $34.94 M

What is Yumanity Therapeutics TTM CFI year-on-year change?

Over the past year, YMTX TTM cash flow from investing activities has changed by -$31.73 M (-90.82%)